Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Ulf Andreasson

Reader

Ulf Andreasson
Reader
ulf.andreasson@neuro.gu.se
+46 31-343 0307

Postal Address: Neurokemi, hus V3, SU/Mölndals sjukhus, 431 80 Mölndal
Visiting Address: Neurokemi, Hus V3, SU/Mölndals sjukhus


Department of Psychiatry and Neurochemistry at Institute of Neuroscience and Physiology (More Information)
Blå stråket 15, vån 3 SU/Sahlgrenska
413 45 Göteborg
031-342 10 00
Visiting Address: Blå stråket 15, vån 3 SU/Sahlgrenska , 413 45 Göteborg

Latest publications

Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg.
Pawel Obrocki, Ayesha Khatun, Deborah Ness, Konstantin Senkevich, Jörg Hanrieder et al.
Alzheimer's research & therapy, Review article 2020
Review article

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.
Claire Bridel, Wessel N van Wieringen, Henrik Zetterberg, Betty M Tijms, Charlotte E Teunissen et al.
JAMA neurology, Journal article 2019
Journal article

Dynamics of extracellular matrix proteins in cerebrospinal fluid and serum and their relation to clinical outcome in human traumatic brain injury
Karolina Minta, N. C. Cullen, F. A. Nimer, E. P. Thelin, F. Piehl et al.
Clinical Chemistry and Laboratory Medicine, Journal article 2019
Journal article

Pre-analytical stability of novel cerebrospinal fluid biomarkers
E. A. J. Willemse, Y. Vermeiren, M. S. Garcia-Ayllon, C. Bridel, P. P. De Deyn et al.
Clinica Chimica Acta, Journal article 2019
Journal article

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
I. Bos, S. Vos, F. Verhey, P. Scheltens, C. Teunissen et al.
Alzheimers & Dementia, Journal article 2019
Journal article

Showing 101 - 110 of 148

2012

Amyloid-β(1-15/16) as a marker for γ-secretase inhibition in Alzheimer's disease.
Erik Portelius, Henrik Zetterberg, Robert A Dean, Alexandre Marcil, Philippe Bourgeois et al.
Journal of Alzheimer's disease : JAD, Journal article 2012
Journal article

Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease.
Vladimir Coric, Christopher H van Dyck, Stephen Salloway, Niels Andreasen, Mark Brody et al.
Archives of neurology, Journal article 2012
Journal article

Analytical aspects of molecular Alzheimer's disease biomarkers
Ulf Andreasson, E. Vanmechelen, L. M. Shaw, Henrik Zetterberg, H. Vanderstichele
Biomarkers in Medicine, Review article 2012
Review article

Measurement of Aβ1-42 in cerebrospinal fluid is influenced by matrix effects.
J Randall Slemmon, Jere Meredith, Valerie Guss, Ulf Andreasson, Henrik Zetterberg et al.
Journal of neurochemistry, Journal article 2012
Journal article

2011

Showing 101 - 110 of 148

Page Manager: Webbredaktör|Last update: 9/1/2015
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?